Lupin-Goa gets US nod to manufacture epilepsy medicines

Global pharmaceutical manufacturer Lupin Limited has received the necessary clearances from the US Food and Drug Administration (FDA) to manufacture and sell medicines used to treat a severe form of epilepsy, which causes seizures in young children. The Mumbai-based drug maker said that the generic drug will be manufactured at Lupin’s facility in Goa.